Niagen Bioscience Inc (NAGE)
NASDAQ: NAGE
· Real-Time Price · USD
10.01
0.30 (3.09%)
At close: Aug 15, 2025, 3:59 PM
10.05
0.40%
After-hours: Aug 15, 2025, 07:52 PM EDT
Niagen Bioscience Inc Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 3.61M | 5.06M | 7.18M | 1.88M | -15K | -492K | 114K | -959K | -2.19M | -1.9M | -1.42M | -985K | -6.4M | -7.74M | -5.33M | -8.86M | -5.57M | -7.38M |
Depreciation & Amortization | 355K | 368K | 358K | 366K | 370K | 390K | 373K | 448K | 444K | 440K | 455K | 449K | 431K | 549K | 388K | 416K | 415K | 407K |
Stock-Based Compensation | 1.49M | 1.07M | 752K | 735K | 1.19M | 984K | 1.04M | 1.12M | 1.32M | 1.27M | 1.33M | 1.23M | 1.3M | 1.89M | 1.47M | 1.82M | 1.62M | 1.28M |
Other Working Capital | -1.44M | 597K | 938K | 28K | -1.8M | 1.06M | -393K | 739K | -398K | 1.71M | 1.54M | -2.9M | -1.15M | 1.63M | -65K | -307K | -1.84M | 1.07M |
Other Non-Cash Items | 102K | -1.37M | -4.9M | 13K | 33K | 56K | 37K | 212K | 418K | 310K | 25K | -49K | -57K | -86K | 22K | -219K | -10K | 14K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -4.3M | 2.75M | 5.19M | 503K | -1.84M | -643K | -912K | -422K | 3.29M | 2.67M | -716K | -4.38M | 895K | -1.81M | -1.5M | 918K | -4.35M | 271K |
Operating Cash Flow | 1.25M | 7.88M | 8.58M | 3.5M | -264K | 295K | 649K | 396K | 3.28M | 2.79M | -328K | -3.74M | -3.83M | -7.2M | -4.94M | -5.92M | -7.89M | -5.41M |
Capital Expenditures | -135K | -32K | -69K | -41K | -12K | -41K | -21K | -26K | -10K | -91K | -172K | -52K | -85K | -25K | -2K | -96K | -265K | -46K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 20K | n/a | n/a | n/a | n/a | 5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -135K | -32K | -69K | -21K | -12K | -41K | -21K | -26K | -5K | -91K | -172K | -52K | -85K | -25K | -2K | -96K | -265K | -46K |
Debt Repayment | -3K | -3K | -2K | -4K | -2K | -3K | -1K | -3K | -10K | -1K | -6K | -3K | -4K | -3K | -4K | -2K | -10K | -15K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -6K | -6K | -41K | n/a | n/a | -11K | -75K | n/a | n/a | n/a | -62K | -15K | n/a | n/a | 67K | 341K | 388K | 8.59M |
Financial Cash Flow | 3.74M | 3.1M | 3.75M | 1.04M | 596K | -14K | -76K | -3K | -10K | -1K | 7.68M | -18K | -4K | -3K | 63K | 339K | 2.25M | 33.45M |
Net Cash Flow | 4.86M | 10.96M | 12.26M | 4.51M | 320K | 240K | 552K | 367K | 3.27M | 2.7M | 7.18M | -3.81M | -3.92M | -7.23M | -4.88M | -5.68M | -5.91M | 27.99M |
Free Cash Flow | 1.11M | 7.85M | 8.51M | 3.45M | -276K | 254K | 628K | 370K | 3.27M | 2.7M | -500K | -3.79M | -3.92M | -7.22M | -4.95M | -6.01M | -8.16M | -5.45M |